Science Explorer Interactive view Map
Company · Issy-les-Moulineaux · France

Johnson & Johnson (France)

jnj.com/france/overviewROR OpenAlex
World rank, all time
#35,024
of 42,892
Rank in France
#1,916
of 2,321
Research works
130
▲ 33% vs 2013–17
Citations
4k
30.7 per fractional work
Top-10% rate
8.7%
record average 16.5%
Open access
37%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 0.78× its world share, 1 worksBiochemistry, Geneti…Immunology and Microbiology: 3.33× its world share, 1 worksImmunology and Micro…Neuroscience: 0.19× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 8.20× its world share, 1 worksPharmacology, Toxico…Computer Science: 0.12× its world share, 0 worksComputer ScienceEarth and Planetary Sciences: 0.14× its world share, 0 worksEarth and Planetary …Engineering: 0.20× its world share, 1 worksEngineeringEnvironmental Science: 0.32× its world share, 0 worksEnvironmental ScienceMaterials Science: 0.45× its world share, 0 worksMaterials ScienceHealth Professions: 2.49× its world share, 1 worksHealth ProfessionsMedicine: 3.79× its world share, 15 worksMedicineEconomics, Econometrics and Finance: 0.99× its world share, 0 worksEconomics, Econometr…Psychology: 0.09× its world share, 0 worksPsychologySocial Sciences: 0.01× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 8.2×. Every wedge is a field page.

Who are the top researchers at Johnson & Johnson (France)?

Ranked on the composite score, Georgios N. Stamatas lead among researchers whose main affiliation is Johnson & Johnson (France).

  1. 1 Georgios N. Stamatas France · #194,198 worldwide 129 citations · 28 works
All ranked researchers at Johnson & Johnson (France)

Which keywords describe research at Johnson & Johnson (France)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Epidemiology, Guidelines, Skin Barrier Function, Skin Cancer, Revision Surgery, Total Hip Replacement, Mortality and Risk Factors.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 23 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 23 words, with their numbers
  1. Epidemiology3▲ 4.1×12 topics
  2. Guidelines2▲ 19×5 topics
  3. Skin Barrier Function2▲ 246×2 topics
  4. Skin Cancer2▲ 106×2 topics
  5. Revision Surgery2▲ 59×2 topics
  6. Total Hip Replacement2▲ 59×2 topics
  7. Mortality2▲ 12×4 topics
  8. Risk Factors2▲ 6.4×7 topics
  9. Matrix Metalloproteinases1▲ 44×2 topics
  10. Oxidative Stress1▲ 3.6×2 topics
  11. Autoantibodies1▲ 25×4 topics
  12. Deep Learning1▲ 1.63×3 topics
  13. Inflammation1▲ 2.6×5 topics
  14. Photoaging1▲ 191×1 topic
  15. Quality of Life1▲ 3.9×4 topics
  16. UV Radiation1▲ 127×1 topic
  17. Complications1▲ 11×2 topics
  18. Filaggrin1▲ 103×1 topic
  19. Infant Skin1▲ 778×1 topic
  20. Skin Barrier1▲ 778×1 topic
  21. Skin Microbiome1▲ 103×1 topic
  22. Health-related Quality of Life1▲ 20×2 topics
  23. Immunotherapy1▲ 6.8×5 topics

Which research topics does Johnson & Johnson (France) publish most on?

By volume in 2022–2025: Skin Protection and Aging, Dermatology and Skin Diseases, Neonatal skin health care and Cardiac, Anesthesia and Surgical Outcomes.

Skin Protection and Aging1Skin Protection and Aging: 1 fractional worksDermatology and Skin Dis…1Dermatology and Skin Diseases: 1 fractional worksNeonatal skin health care1Neonatal skin health care: 1 fractional worksCardiac, Anesthesia and …1Cardiac, Anesthesia and Surgical Outcomes: 1 fractional worksTotal Knee Arthroplasty Outcomes: 1 fractional worksAdvancements in Transdermal Drug Delivery: 1 fractional worksSystemic Lupus Erythemat…1Systemic Lupus Erythematosus Research: 1 fractional worksAllergic Rhinitis and Sensitization: 1 fractional worksOrthopaedic implants and arthroplasty: 1 fractional worksCell Image Analysis Tech…1Cell Image Analysis Techniques: 1 fractional works
DermatologySpeech and HearingCardiology and Cardiovascular MedicineSurgery4 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Skin Protection and Aging Dermatology 1 works
  2. 2 Dermatology and Skin Diseases Dermatology 1 works
  3. 3 Neonatal skin health care Speech and Hearing 1 works
  4. 4 Cardiac, Anesthesia and Surgical Outcomes Cardiology and Cardiovascular Medicine 1 works
  5. 5 Total Knee Arthroplasty Outcomes Surgery 1 works
  6. 6 Advancements in Transdermal Drug Delivery Pharmaceutical Science 1 works
  7. 7 Systemic Lupus Erythematosus Research Rheumatology 1 works
  8. 8 Allergic Rhinitis and Sensitization Immunology and Allergy 1 works
  9. 9 Orthopaedic implants and arthroplasty Surgery 1 works
  10. 10 Cell Image Analysis Techniques Biophysics 1 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.9%not open63.1%

World: 28% of research is openly available.

with international co-authors48.0%domestic only52.0%

World: 19% is written across borders.

How has Johnson & Johnson (France)'s research output changed?

Output in 2018–2022 was 33% higher than in 2013–2017.

20002005201020152020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Issy-les-Moulineaux

All research institutions in Issy-les-Moulineaux

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.